weeks 1-16 on tirzepatide Semaglutide GI rate / 44.2% nausea, 31.5% diarrhea, 23.4% constipation in STEP-1 (N=1,961) Tirzepatide GI rate / approximately 80% of patients on 15 mg reported at least one GI effect in SURMOUNT-1 (N=2,539) First-line fix / avoid high-sulfur foods (eggs, garlic, cruciferous vegetables) on injection days Medication option / simethicone (Gas-X, 125 mg) or bismuth subsalicylate (Pepto-Bismol) may reduce odor and frequency Serious warning / new right-upper-quadrant pain plus burping may signal gallbladder disease, not routine GI upset Discontinuation / roughly 7% of semaglutide 2.4 mg patients stopped due to GI side effects in STEP-1 Dose strategy / slower titration reduces GI burden without meaningfully reducing weight loss outcomes What Causes Sulfur Burps on GLP-1 Drugs GLP-1 receptor agonists slow gastric emptying as a deliberate pharmacological effect

A number of studies have found that GLP-1 receptor agonists can 9: Reduce body weight and waist circumference Improve insulin resistance (measured by HOMA-IR) Lower fasting glucose and insulin levels These changes may contribute to improvements in ovulatory function and menstrual regularity, particularly in individuals with overweight or obesity
The cardiovascular safety profile, the long-term durability of weight loss, the side effect profile at scale, all of that is still being established
By boosting your B12 levels, youre not just improving your overall health but youre also potentially enhancing your bodys ability to lose weight by increasing energy levels and improving metabolism
(PubMed) Savitha S, Sivarajan K, Haripriya D, Kokilavani V, Panneerselvam C
Body Composition: Body fat percentage can influence how medications are absorbed and metabolized, potentially affecting how long GLP-1 is active